Federal workplaces would be required to have opioid overdose reversal medication and train staff.
This bill would require federal government workplaces to keep opioid overdose reversal medication on hand and train their employees to use it every year. It would also offer nonmandatory guidance to most other private employers on doing the same, aiming to make workplaces safer.
Today, there are no specific federal requirements for workplaces to have opioid overdose reversal medication or to train employees on its use. If this bill becomes law, federal agencies would be required to acquire this medication and provide annual employee training. Most other private employers would receive official, but nonmandatory, guidance from the government on these same practices.
S 3812 · 119th Congress · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
5 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.